Vaxcyte, Inc.
PCVX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649094
In the last 90 days, Vaxcyte, Inc. insiders filed 0 open-market purchases and 8 sales; 331 institutions reported holding it in 13F filings for Q2 2026, worth $9.71B in total; Maverick Capital is the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding Vaxcyte, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 251 | 1 | 265 | +15 |
| Shares | 119.1M | 124.0K | 122.6M | +3.59M (+3.0%) |
| Value | $8.13B | $8.47M | $9.26B | +$1.14B (+14.0%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (38)
Institutions that held Vaxcyte, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (23)
Institutions that held Vaxcyte, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Samlyn Capital, LLC | 302,679 | $20.7M |
| Capstone Investment Advisors, LLC | 109,389 | $7.47M |
| Monashee Investment Management LLC | 100,000 | $6.83M |
| Alps Advisors Inc | 76,316 | $5.21M |
| Healthcare of Ontario Pension Plan Trust Fund | 59,400 | $4.06M |
| American International Group, Inc. | 52,313 | $3.57M |
| Twinbeech Capital LP | 31,647 | $2.16M |
| Jump Financial, LLC | 30,224 | $2.06M |
| Walleye Capital LLC | 29,707 | $2.03M |
| Maven Securities LTD | 15,000 | $1.02M |
| Harvest Investment Services, LLC | 8,663 | $591.8K |
| Scientech Research LLC | 7,289 | $497.9K |
| Bridgefront Capital, LLC | 6,594 | $450.4K |
| Bayesian Capital Management, LP | 6,028 | $411.8K |
| Metropolitan Life Insurance Co | 5,573 | $380.7K |
| Engineers Gate Manager LP | 5,554 | $379.4K |
| Rathbone Brothers plc | 4,330 | $295.8K |
| Virtus Investment Advisers, Inc. | 3,178 | $217.1K |
| Banque Cantonale Vaudoise | 1,184 | $81.0K |
| Catalyst Funds Management Pty Ltd | 400 | $27.3K |
| Citadel Advisors LLC | 119 | $8.13K |
| Quantbot Technologies LP | 57 | $3.89K |
| Massmutual Trust Co FSB | 7 | $478 |
Not filed for Q2 2024 yet (1)
Institutions that held Vaxcyte, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 123,970 | $8.47M |